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Natural killer T (NKT) cells are prominent innate-like lymphocytes in the liver with critical 
roles in immune responses during infection, cancer, and autoimmunity. Interferon gamma 
(IFN-γ) and IL-4 are key cytokines rapidly produced by NKT cells upon recognition of 
glycolipid antigens presented by antigen-presenting cells (APCs). It has previously been 
reported that the transcriptional coactivator β-catenin regulates NKT cell differentiation 
and functionally biases NKT cell responses toward IL-4, at the expense of IFN-γ produc-
tion. β-Catenin is not only a central effector of Wnt signaling but also contributes to other 
signaling networks. It is currently unknown whether Wnt ligands regulate NKT cell func-
tions. We thus investigated how Wnt ligands and β-catenin activity shape liver NKT cell 
functions in vivo in response to the glycolipid antigen, α-galactosylceramide (α-GalCer) 
using a mouse model. Pharmacologic targeting of β-catenin activity with ICG001, as well 
as myeloid-specific genetic ablation of Wntless (Wls), to specifically target Wnt protein 
release by APCs, enhanced early IFN-γ responses. By contrast, within several hours of 
α-GalCer challenge, myeloid-specific Wls deficiency, as well as pharmacologic targeting 
of Wnt release using the small molecule inhibitor IWP-2 impaired α-GalCer-induced 
IFN-γ responses, independent of β-catenin activity. These data suggest that myeloid 
cell-derived Wnt ligands drive early Wnt/β-catenin signaling that curbs IFN-γ responses, 
but that, subsequently, Wnt ligands sustain IFN-γ expression independent of β-catenin 
activity. Our analyses in ICG001-treated mice confirmed a role for β-catenin activity in 
driving early IL-4 responses by liver NKT  cells. However, neither pharmacologic nor 
genetic perturbation of Wnt production affected the IL-4 response, suggesting that IL-4 
production by NKT cells in response to α-GalCer is not driven by released Wnt ligands. 
Collectively, these data reveal complex temporal roles of Wnt ligands and β-catenin 
signaling in the regulation of liver NKT cell activation, and highlight Wnt-dependent and 
-independent contributions of β-catenin to NKT cell functions.
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decreases thymic NKT cell numbers, in contrast to increases in 
NKT cell numbers upon transgenic β-catenin overexpression. In 
these experiments, IL-4- and IL-17-expressing NKT cell subsets 
were primarily affected (20). Moreover, differentiation of IL-4-
producing NKT  cells in the periphery was governed by Lef-1 
activity (21). Stimulation of β-catenin-overexpressing NKT cells 
in vitro and in vivo resulted in decreased IFN-γ expression, and 
increased IL-4, IL-13, and IL-17 production, consistent with the 
effects on the development of NKT cell subsets in these mice (20). 
These observations strongly suggest key roles for β-catenin and 
its interaction partners, TCF and LEF, in the development and 
functions of NKT cells.
The complex phenotypical changes in genetically targeted 
mouse models have thus far made it difficult to separate effects 
on NKT cell development from functional effects on NKT cells 
upon antigen encounter. Furthermore, whether Wnt ligands 
are directly involved in the governance of NKT  cell functions 
in  vivo remains unknown. Evidence that Wnt ligands regulate 
T cell responses, at least in part by modulating functions of APCs 
(22, 23), led us to hypothesize that Wnt proteins exert similar 
regulatory functions on NKT cell activation. We thus employed 
pharmacologic and genetic perturbation of Wnt production and 
β-catenin to investigate how β-catenin activity and Wnt ligands 
shape NKT cell cytokine responses in vivo using the model anti-
gen, α-galactosylceramide (α-GalCer).
MaTerials anD MeThODs
Mice
C57BL/6 mice were bred in house or obtained from the Animal 
Resources Centre (Perth, WA, Australia). Tcf/Lef TOPFlash 
reporter mice, which express luciferase as a reporter of Tcf/
Lef transcriptional activity (24), were bred to obtain mice 
heterozygous for the transgene or wild-type littermate con-
trols. Conditional Wls knockout mice (Wlsfl/fl LysM-Cre+) and 
their littermate controls (Wlsfl/fl LysM-Cre−) were obtained by 
backcrossing Wlsfl/fl mice (25) with C57BL/6 mice for 10 genera-
tions, and subsequent cross-breeding with mice expressing Cre 
recombinase driven by the Lysozyme M promoter (LysM-Cre) 
(7), backcrossed for at least 7 generations with C57BL/6. Mice 
were housed under specific pathogen-free conditions with food 
and water ad libitum. All procedures involving animals adhered 
to the guidelines of the National Health and Medical Research 
Council Australian Code for the Care and Use of Animals for 
Scientific Purposes, and were approved by the Animal Ethics 
Committee of The University of Queensland (UQDI/571/12; 
UQDI/554/15) and the University of Melbourne Animal Ethics 
Committee (06089).
Male and female mice aged 8–14 weeks were housed in microi-
solator cages (Technoplast) with corncob bedding, nesting mate-
rial, and houses. Mice were injected intravenously, during the 
light cycle, with 2 µg α-GalCer (KRN7000; Funakoshi Company), 
or an equivalent volume of vehicle control (5.6% sucrose/0.75% 
l-histidine/0.5% Tween 20 in PBS). ICG001 (20  mg/kg; Tocris 
Bioscience) and IWP2 (20  mg/kg; Tocris Bioscience), or an 
equivalent volume of DMSO (Sigma-Aldrich) as a vehicle control, 
Abbreviations: α-GalCer, α-galactosylceramide; APC, antigen-presenting cell; 
Dkk, Dickkopf; Fzd, Frizzled; IFN-γ, interferon gamma; IL, interleukin; Lef, lym-
phoid enhancing factor; LysM, lysozyme M; NKT cell, natural killer T cell; Sfrp, 
soluble Frizzled-related protein; Tcf, T cell factor; Wls, Wntless.
inTrODUcTiOn
Natural killer T (NKT) cells are an important population of 
hepatic lymphocytes in both humans and mice (1). These innate-
like lymphocytes orchestrate immune responses against viral and 
bacterial infections, as well as during carcinogenesis, autoim-
munity, injury, and fibrosis (2, 3). NKT  cells respond rapidly 
to glycolipid antigens presented by the MHC-I-like molecule 
CD1d, in conjunction with co-stimulation via CD40 on antigen-
presenting cells (APCs) with CD40L on NKT cells (4). Antigen 
presentation by APCs and recognition by NKT cells, as well as 
CD40/CD40L ligation elicit cytokine production by both APCs 
(e.g., IL-12) and NKT  cells [interferon gamma (IFN-γ), IL-4, 
IL-17], among other cellular responses (4, 5). The concerted 
actions of these cytokines determine the flavor of NKT cell con-
tributions to immune responses in the liver environment.
Hepatic Wnt proteins are central regulators of cell prolifera-
tion, differentiation, and functionality during liver injury, repair, 
regeneration, as well as homeostasis (6, 7). Their roles are complex 
and often context dependent. More recently, Wnt ligands have 
emerged as important regulators of immune responses during 
infection, cancer, and autoimmunity (8–10). The 19 mammalian 
Wnt proteins engage receptors of the Frizzled (Fzd) family, 
together with co-receptors including low-density lipoprotein 
receptor-related proteins (LRP) 5/6, receptor tyrosine kinase-like 
orphan receptor (Ror), and receptor-like tyrosine kinase (Ryk) 
(11). Palmitoylation of Wnt proteins by the acyltransferase 
Porcupine in the endoplasmic reticulum, as well as subsequent 
binding to the chaperone Wntless (Wls), are required for the 
functionality and release of most Wnt proteins from secreting 
cells (12–14). Depending on the nature of the Wnt/Wnt receptor 
complex, Wnt proteins activate cells via β-catenin-dependent or 
-independent signaling pathways. In the absence of Wnt ligation, 
casein kinase-1 and glycogen synthase kinase-3β phosphorylate 
β-catenin within the β-catenin destruction complex, which also 
contains the scaffold proteins adenomatous polyposis coli and 
axis inhibition (Axin). Phosphorylated β-catenin is targeted 
for proteasomal degradation (15). Wnt/receptor engagement 
inactivates the destruction complex, stabilizes β-catenin, and 
enables its nuclear translocation, where it acts as a coactivator for 
transcription factors of the T cell factor (TCF)/lymphoid enhanc-
ing factor (LEF) family (15). By contrast, β-catenin-independent 
signaling comprises different pathways, including the Wnt/Ca2+, 
JNK, and planar cell polarity pathways, which govern cytoskeletal 
rearrangements and cell polarization (11). Wnt signaling is highly 
regulated by soluble factors including Wnt inhibitory factor (Wif), 
Dickkopf (Dkk) family members, and soluble Frizzled-related 
proteins (sFRPs) (16).
β-Catenin has been implicated in directing NKT cell develop-
ment and functions (17). LEF-1-binding sites are present in the 
human CD1D promoter, and LEF-1 negatively regulates CD1D 
expression (18, 19). In mice, conditional knockout of β-catenin 
Table 1 | List of primers used in quantitative PCR.
gene Forward primer (5′-3′) reverse primer (5′-3′) reference
Hprt GCCCCAAAATGGTTAAGGTTGC AACAAAGTCTGGCCTGTATCCAAC
Cd1d CCTATTTGTCCGTGGTCTCC ACAGGTTTTGGGTAGAAGCC
Cd40 CTGTGAGGATAAGAACTTGGAGG AGAGAAACACCCCGAAAATGG
Dkk1 ATATCCCAGAAGAACCACACTG ATCTTGGACCAGAAGTGTCTTG
Ifng GAACTGGCAAAAGGATGGTGA TGTGGGTTGTTGACCTCAAAC
Il12b GGAAGCACGGCAGCAGAATA AACTTGAGGGAGAAGTAGGAATGG (27)
Il4 CGAATGTACCAGGAGCCATATC TCTCTGTGGTGTTCTTCGTTG
Luciferase GGCGCGTTATTTATCGGAGTT GTTGAGCAATTCACGTTCAT
Sfrp1 AATGTGACAAGTTCCCCGAG GATGGCCTCTGACTTCAACTC
Tbx21 CAACAACCCCTTTGCCAAAG TCCCCCAAGCAGTTGACAGT (28)
Wnt1 GATTTTGGTCGCCTCTTTGG CGTGGCATTTGCACTCTTG
Wnt2 GTAGATGCCAAGGAGAGGAAAG CCAGCATGTCCTCAGAGTAC
Wnt2b GCCCTCATGAACTTACACAAC CTGTGCGTCGGAAGTCTG
Wnt3 CCCGCTCAGCTATGAACAAG ACTTTAGGTGCATGTGGTCC
Wnt3a GTGAGGACATTGAATTTGGAGG ACTTGAGGTGCATGTGACTG
Wnt4 AGTGCCAATACCAGTTCCG AGAGATGGCGTATACAAAGGC
Wnt5a CGCTAGAGAAAGGGAACGAATC CTCCATGACACTTACAGGCTAC
Wnt5b GACTGACGCCAACTCCTG TGCTCCTGATACAACTGACAC
Wnt6 TCAAGACTCTTTATGGATGCGC ATGGCACTTACACTCGGTG (7)
Wnt7a ACGAGTGTCAGTTTCAGTTCC AATCGCATAGGTGAAGGCAG
Wnt7b AATGAGGCGGGCAGAAAG TGCGTTGTACTTCTCCTTGAG
Wnt8a TCATGTACGCAGTCACCAAG TTTTCCCCGAACTCCACG
Wnt8b GTACACCCTGACTAGAAACTGC AAACTGCTTGGAAATTGCCTC
Wnt9a GGGACAACCTCAAGTACAGC TTCCACTCCAGCCTTTATCAC
Wnt9b CCAAGAGAGGAAGCAAGGAC AACAGGTACGAACAGCACAG
Wnt10a CGCTTCTCTAAGGACTTTCTGG GTGGCATTTGCACTTACGC
Wnt10b TCTCGGGATTTCTTGGATTCC CATTTGCACTTCCGCTTCAG
Wnt11 CCAAGCCAATAAACTGATGCG GGCATTTACACTTCGTTTCCAG
Wnt16 CGAGAGGTGGAACTGTATGG TGAATGCTGTCTCCTTGGTG
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were diluted in PBS and injected intraperitoneally 16 h prior to 
α-GalCer injection.
Flow cytometry
To obtain single cell suspensions, liver tissues were mechanically 
disrupted, cells pelleted, and resuspended in 7.5 mL PBS and 4.5 
mL isotonic Percoll (Sigma-Aldrich), and centrifuged at room 
temperature for 15 min at 760 × g. Leukocytes and red blood cells 
(RBCs) were harvested, and RBCs lysed in lysis buffer (0.15 M 
NH4Cl, 1  mM KHCO3, 0.1  mM EDTA). Intracellular cytokine 
staining was performed on leukocytes using the Cytofix/Cytoperm 
kit (BD Biosciences) according to the manufacturer’s instruc-
tions. Fc receptor binding was blocked with anti-mouse CD16/32 
(2.4G2; BD Pharmingen) before addition of antibodies against 
mouse CD3 (145-2C11 or 17A2; PE, PerCP or eFluor 450; eBio-
science), NK1.1 (PK136; APC; eBioscience and BD Pharmingen), 
Fzd1 (162531; biotin; R&D Systems), Fzd7 (151143; biotin; R&D 
Systems), TCRβ (H57-597; BV421; BioLegend), CD11b (M1/70; 
PE; BD Pharmingen), Ly-6G (1A8; Alexa Fluor 700; BioLegend), 
Ly-6C (AL-21; PE-Cy7; BD Biosciences), IFN-γ (XMG1.2; FITC; 
BD Pharmingen), and IL-4 (BVD4-1D11; PE; BD Pharmingen). 
Streptavidin-PE-Cy7 (BD Pharmingen) was used for detection 
of biotinylated antibodies. α-GalCer-loaded CD1d tetramer (PE) 
was generated in-house using a baculovirus expression system, 
similar to that previously described (26). Samples were acquired 
on a BD FACSCanto or Beckman Coulter Gallios and analyzed 
using FlowJo software (TreeStar, Inc.).
bone Marrow-Derived Macrophages
Bone marrow cells from femurs and tibias of male and female mice 
aged 8–14  weeks were cultured in DMEM (Life Technologies) 
containing 10% FBS (Bovogen Biologicals), 2 mM l-glutamine, 
1 mM sodium pyruvate, 10 mM HEPES (all Life Technologies), 
and 20% L cell-conditioned medium. Fresh medium (one-fifth of 
original volume) was added every second day. After 6 days, adher-
ent cells were harvested by washing with warm PBS, followed by 
incubation with cold 0.1 M EDTA in PBS for 10 min at 4°C. Cells 
were washed with cold PBS, centrifuged, and resuspended in 
TRIzol (Life Technologies).
Quantitative real-time Pcr
RNA was isolated from liver tissue using TRIzol, and 1 µg total 
RNA was reverse transcribed with the iScript cDNA synthesis 
kit (Bio-Rad Laboratories). Quantitative real-time PCR was per-
formed with SYBR Green PCR master mix (Life Technologies) 
using an ABI Prism 7900HT (PerkinElmer). Expression of genes 
of interest was normalized to the housekeeping gene hypoxanthine 
guanine phosphoribosyl transferase (Hprt) [2(Ct value Hprt − Ct value gene 
of interest)] and is depicted as relative gene expression. Gene-specific 
primers were designed using the Integrated DNA Technologies 
online primer design tool or were previously published (Table 1).
elisa
Mouse IFN-γ (R&D Systems) and IL-12p40 (BD Biosciences) 
ELISA kits were used according to the manufacturer’s protocols 
4Kling et al. Wnts Regulate NKT Cell IFN-γ
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to determine cytokine concentrations in mouse serum. Serum 
concentrations of IL-4 were determined using a sandwich ELISA. 
Maxisorp plates (Nunc) were coated with anti-mouse IL-4 cap-
ture antibody (2 µg/mL; 11B11; BioLegend) in 50 mM sodium 
bicarbonate buffer (pH 9.4) overnight. Plates were washed with 
0.05% Tween 20 (Sigma-Aldrich) in PBS, blocked with 4% bovine 
serum albumin (BSA; Roche) in PBS for 2 h, and then samples 
and standards (mouse rIL-4; Peprotech), serially diluted two-fold 
from 2,000 pg/mL, were added for 1 h. Anti-mouse IL-4 detec-
tion antibody (0.5  µg/mL; BVD6-24G2, BioLegend) diluted in 
4% BSA in PBS was added for 1 h, followed by HRP-conjugated 
streptavidin (2  µg/mL; Sigma-Aldrich) for 30  min. The plates 
were developed with TMB substrate (BD Biosciences), and the 
reaction stopped with 1 M H2SO4 (Sigma-Aldrich).
Microarray analysis
Natural killer T  cells were purified from liver lymphocytes by 
flow cytometric cell sorting as α-GalCer-CD1d-tetramer+ TCRβ+ 
NK1.1+ cells and further divided on the basis of CD4 expression. 
The purity of CD4− and CD4+ NKT cell subsets analyzed by flow 
cytometry post-sort was >96%. Sorted NKT  cell subsets (four 
samples/group) were stimulated with Dynabeads Mouse CD3/
CD28 T Cell Expander Beads (Invitrogen) at a 1:1 ratio of beads 
to cells for 2  h at 37°C. RNA was extracted from stimulated 
NKT cell subsets (Qiagen RNeasy and Qiashredder), RNA yield 
quantified spectrophotometrically on a Nanodrop ND-1000 and 
aliquots electrophoresed for determination of sample concentra-
tion and purity. Microarray hybridizations were performed using 
100 ng RNA and the WT Expression kit (Life Technologies), WT 
Terminal Labeling and Controls Kit (Affymetrix), and Affymetrix 
Mouse Gene_1.0ST arrays (770,317 probe sets representing an 
estimated 35,556 mouse transcripts). The probed arrays were 
washed and stained using the GeneChip Hybridization Wash 
and Stain Kit (Affymetrix), and scanned using the GeneChip 
Scanner 3000. Images (.dat files) were processed using GeneChip 
Command Console (Affymetrix) and CEL files imported into 
Partek Genomics Suite 6.6 (Partek SG) for further analysis as 
published previously (29, 30).
statistical analyses
One- or two-way ANOVA with Dunnett’s or Bonferroni’s 
correction for multiple comparisons, or unpaired two-sided 
Student’s t-test were performed as indicated using Graphpad 
Prism (Graphpad Software, Inc.). P values <0.05 were considered 
statistically significant.
resUlTs
α-galcer rapidly induces Dynamic 
regulation of iFn-γ and il-4  
responses in the liver and serum
α-Galactosylceramide rapidly induces IFN-γ and IL-4 expres-
sion by NKT cells (5), accompanied by transient downregulation 
of several distinguishing surface markers (31). To reliably detect 
liver CD3+NK1.1+ NKT cells in α-GalCer-challenged mice, we 
established an intracellular flow cytometry protocol for CD3 and 
NK1.1 to track NKT cells in vivo early after α-GalCer challenge 
(Figure 1). Consistent with previous reports (31), CD3, NK1.1, 
and CD1d tetramer surface staining was reduced after α-GalCer 
challenge (left panel). As CD1d tetramer was unable to enter cells 
upon permeabilization, antibodies against CD3 and NK1.1 were 
used for intracellular staining. Importantly, while NKT  cells 
exhibit dim CD3 surface staining, they have similar staining 
intensity of intracellular CD3 as CD3+NK1.1− T cells (right panel). 
This allows for better separation of the CD3+NK1.1+ population 
from other cell populations, particularly after challenge. At 1.5 h 
after challenge, a greater proportion of CD3+NK1.1+ was detected 
using the intracellular staining protocol, compared to surface 
only staining. However, similar percentages of CD3+NK1.1+ cells 
were detected at 6  h using either staining protocol, indicating 
that these cells have either degraded CD3 and NK1.1, or are no 
longer present in liver tissue.
We used the intracellular staining method to follow IFN-γ and 
IL-4 expression by liver CD3+NK1.1+ cells after systemic admin-
istration of α-GalCer. A rapid increase of IFN-γ+CD3+NK1.1+ 
cells with 57.8  ±  4.6% cells expressing IFN-γ was observed 
at 1.5  h and 51.6 ±  4.6% at 3  h post challenge (Figure  2A). 
By contrast, the proportion of IFN-γ+CD3+NK1.1− cells 
peaked at 9.7 ±  1.6% at 1.5  h after challenge (Figure S1A in 
Supplementary Material) suggesting that at these early time 
points, the majority of cells expressing IFN-γ in response to 
α-GalCer challenge are CD3+NK1.1+ NKT  cells. This was 
accompanied by a significant increase in liver Ifng mRNA 
expression (Figure  2B) and gradually increasing concentra-
tions of IFN-γ in the serum (Figure 2C). While the percentage 
of CD3+NK1.1+ cells expressing IFN-γ declined to 32.2 ±  3.7 
and 18.0 ± 2.1% at 4.5 and 6 h post challenge, respectively, the 
Ifng mRNA expression as well as IFN-γ serum concentrations 
remained elevated (Figures  2A–C). This is likely reflective of 
secondary contributions by IFN-γ-producing CD3−NK1.1+ 
NK cells (Figure S1B in Supplementary Material).
The percentage of liver CD3+NK1.1+ cells expressing IL-4 
gradually increased over the first 6  h after α-GalCer challenge 
allowing for IL-4 detection in the serum by 6 h. This was pre-
ceded by a transient upregulation of liver Il4 mRNA expression 
that peaked at 1.5  h after α-GalCer challenge (Figures  2D–F). 
A similar percentage of CD3+NK1.1− cells and CD3+ NK1.1+ 
cells expressed IL-4, which may be attributable to the presence of 
NK1.1− NKT cells (32) (Figure S1C in Supplementary Material).
suppression of β-catenin activity 
Facilitates iFn-γ expression but limits 
il-4 responses after α-galcer challenge 
In Vivo
Previous studies have indicated that β-catenin contributes to 
NKT  cell development, particularly affecting IL-4-expressing 
NKT cells (20, 21). As genetic modulation of β-catenin expression 
affects NKT cell development in vivo (20, 21), we chose a small 
molecule inhibitor approach to assess the role of β-catenin activ-
ity in antigen-driven NKT  cell activation in mice with normal 
NKT cell development. ICG001 inhibits β-catenin interaction with 
CREB-binding protein (CBP) (33) and has been successfully used 
FigUre 1 | Flow cytometry-based detection of liver natural killer T (NKT) cells. Liver leukocytes from naïve or α-GalCer-challenged mice were stained with surface 
CD1d tetramer (CD1d-tet). Half of the liver sample was stained for surface expression of CD3 and NK1.1 (left panel), while the other half was permeabilized for 
intracellular expression of CD3 and NK1.1 (right panel). Various gating strategies for CD3, NK1.1, and CD1d-tet expression over time are shown as a comparison of 
surface and intracellular expression. Putative “NKT” cells from naïve mice (light gray) have been overlayed to show placement within dot plots using the third marker. 
Surface expression of all three markers are reduced as early as 1.5 h after α-galactosylceramide (α-GalCer) challenge (left panel); however, intracellular CD3 and 
NK1.1 expression is sustained at this early time point (right panel). Data are representative of three mice per time point.
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to modulate β-catenin functions in mouse models of fibrosis and 
cholangiocarcinoma (34, 35). Importantly, and in contrast to the 
changes in NKT cell proportions seen in studies with genetically 
altered β-catenin expression throughout NKT cell development, 
ICG001 did not alter the percentages of CD3+NK1.1+ NKT cells 
in naïve mice or after α-GalCer challenge (Figure 3A and data not 
shown). ICG001-treated mice had increased serum IFN-γ con-
centrations at 1.5 and 3 h after α-GalCer challenge (Figure 3B), 
which was accompanied by a trend toward elevated liver Ifng 
mRNA expression and more rapid induction of Tbx21 mRNA 
(encoding for the transcription factor driving Ifng expression) 
(Figures 3C,D). At these early timepoints, the major contributor 
to IFN-γ expression is the CD3+NK1.1+ NKT  cell population 
(Figures S1A,B in Supplementary Material). Interferon gamma 
expression by NKT cells drives IL-12 responses. mRNA expres-
sion of Il12b was significantly higher in liver tissue of ICG001-
treated mice compared to DMSO controls (Figure  3E). This 
effect of ICG001 may be restricted to the liver environment, as 
serum levels of IL-12p40 were comparable between ICG001- and 
DMSO-treated mice (Figure 3F). Similar to Il12b, liver mRNA 
expression of Cd40, a costimulatory molecule expressed by APCs, 
was rapidly induced by α-GalCer challenge with significantly 
FigUre 2 | Rapid induction of interferon gamma (IFN-γ) and IL-4 expression upon α-galactosylceramide (α-GalCer) challenge. Percentages of CD3+NK1.1+ natural 
killer T cells in the liver expressing IFN-γ (a) or IL-4 (D) were determined by flow cytometry. Representative plots for IFN-γ are from 1.5 h post challenge, while IL-4 
expression is demonstrated for 6 h post challenge. Quantitative PCR was performed to determine mRNA expression of Ifng (b) and Il4 (e) in liver tissue upon 
α-GalCer challenge. Serum concentrations of IFN-γ (c) or IL-4 (F) were determined by ELISA. ND, not detected. n = 4–7 mice per time point from two independent 
experiments. One-way ANOVA with Dunnett’s correction for multiple comparisons; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. [Notes (D,F): mice received 
a DMSO-injection prior to α-GalCer challenge; (F): 6-h time point replicated in Figure 4b.]
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higher expression in ICG001-treated mice compared to DMSO 
controls at 1.5 h (Figure S2A in Supplementary Material). There 
were similar percentages of Ly6Chi and Ly6Clo myeloid cells 
(CD11b+Ly6G−) in the liver in DMSO- and ICG001-treated 
mice, after both control and α-GalCer challenge (Figure S2B in 
Supplementary Material), suggesting that an increase in local 
Il12b and Cd40 mRNA expression was likely due to enhanced 
induction of gene expression in APCs rather than differential 
numbers of resident (Ly6Clo, including Kupffer cells) and recruited 
inflammatory (Ly6Chi) monocyte populations. In contrast to the 
early effects on IFN-γ responses, liver Il4 mRNA expression was 
reduced in ICG001-treated mice compared to DMSO controls 
at 4.5  h (Figure  4A), accompanied by reduced serum IL-4 at 
6 h post α-GalCer challenge, when serum concentrations were 
FigUre 3 | β-catenin activity suppresses the IL-12/interferon gamma (IFN-γ) axis upon α-galactosylceramide (α-GalCer) challenge. (a) Percentages of  
CD3+NK1.1+ natural killer T cells in liver tissue after overnight challenge with ICG001, an inhibitor of β-catenin activity, or DMSO. After α-GalCer challenge, (b) serum 
concentrations of IFN-γ were determined by ELISA. The mRNA expression of Ifng (c) and Tbx21 (D) in the liver was determined by quantitative RT-PCR. (e) mRNA 
expression of Il12b in the liver and (F) protein expression of IL-12p40 in the serum. Dotted line represents average concentration of serum IL-12p40 for all 
mock-injected mice. Data are means ± SEM from four to nine mice per treatment for each time point cumulative from two to three independent experiments. 
Groups were compared by unpaired t test at each time point; *p < 0.05, **p < 0.01, N.D., not detectable.
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elevated above levels in naïve DMSO-treated mice (Figure 4B). 
Together, these data suggest that β-catenin activity suppresses 
early α-GalCer-induced IFN-γ responses, while subsequently 
sustaining the IL-4 response.
α-galcer challenge suppresses Wnt/β-
catenin Pathway activity in the liver
While β-catenin signaling has been implicated in NKT cell func-
tions (20), a direct role for Wnt ligands has not yet been established. 
We thus profiled the expression of Wnt ligands in liver tissue of 
mice challenged with α-GalCer. The rapid induction of cytokine 
responses (Figure 2) was accompanied by reduced mRNA expres-
sion of several Wnt ligands, including Wnt2, Wnt4, and Wnt9b 
(Figure  5A), whose expression remained low throughout the 
6 h of α-GalCer challenge. Wnt5b mRNA expression remained 
constant initially, but was significantly reduced at 6 h post chal-
lenge. By contrast, Wnt1 was the only ligand whose expression 
was significantly induced by α-GalCer, peaking at 4.5  h post 
challenge. In contrast, the expression of Wnt2b, Wnt5a, Wnt9a, 
and Wnt11 was not significantly altered in liver tissue of α-GalCer 
challenged mice, and expression of the remaining Wnt ligands 
was below the detection limit under all conditions (Figure 5A). 
Remarkably, expression of the endogenous regulators of Wnt 
signaling, Dkk1 and Sfrp1 (Figures 5B,C) was also significantly 
increased and Tcf/Lef transcriptional activity in liver tissue of 
β-catenin reporter mice (24) was lost upon α-GalCer challenge 
(Figure 5D). Comparable α-GalCer-induced Ifng expression in 
the reporter mice and littermate controls demonstrated equal 
responsiveness to the NKT  cell antigen (Figure  5D). Taken 
FigUre 4 | β-catenin activity promotes IL-4 expression upon α-
galactosylceramide (α-GalCer) challenge. Mice were treated with ICG001, 
then challenged with α-GalCer. (a) The mRNA expression of Il4 in the liver 
was determined by quantitative PCR. (b) Serum concentrations of IL-4 at  
6 h after α-GalCer challenge. Data are means ± SEM from four to nine mice 
per treatment for each time point analyzed cumulatively in two to three 
independent experiments. Groups were compared by t-test at each  
time point; *p < 0.05.
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together, these data are concordant with active suppression of 
Wnt/β-catenin signaling in the liver in response to the NKT cell 
antigen, α-GalCer.
Temporal regulation of α-galcer-induced 
iFn-γ responses by Myeloid cell-Derived 
Wnt ligands
We next sought to establish whether Wnt ligands contribute to the 
α-GalCer-induced cytokine profiles. APCs are a cellular source 
of Wnt ligands during homeostasis and inflammation (22, 36). 
We utilized a mouse model of LysM-Cre-driven Wls ablation in 
myeloid cells, which we have demonstrated to effectively ablate 
Wls expression by F4/80+ liver macrophages (7). Wls deletion 
did not affect numbers and location of liver macrophages (7) and 
CD3+NK1.1+ NKT cells (Figure S3A in Supplementary Material). 
While previous studies reported that LEF-1 negatively regulated 
the transcription of CD1D in human cells (18, 19), LysM-Cre-
driven Wls ablation in mice did not alter expression of Cd1d 
(Figures S3B,C in Supplementary Material).
Wlsfl/fl LysM-Cre+ mice exhibited early increased percentages 
of IFN-γ+ CD3+NK1.1+ cells in the liver compared to littermate 
controls after α-GalCer challenge (Figure 6A). This phenotype 
mirrored to some extent the observations made with the 
β-catenin inhibitor, ICG001 (Figure  3), suggesting that early 
during the response to α-GalCer, myeloid-derived Wnt proteins 
drive β-catenin signaling that curbs hepatic IFN-γ responses. By 
contrast, at 6 h after α-GalCer challenge, IFN-γ concentrations 
in the serum of Wlsfl/fl LysM-Cre+ mice were significantly lower 
compared to littermate controls (Figure 6A). As this was not asso-
ciated with reduced percentages of IFN-γ+ CD3+NK1.1+ (NKT) 
and CD3−NK1.1+ (NK) cells in the liver (Figure 6A; Figure S3D 
in Supplementary Material), regulation of the systemic IFN-γ 
response at this later time point may occur by Wls-expressing 
myeloid cells at locations other than the liver or be shaped by cells 
other than NK and NKT cells. Nevertheless, Wnt ligands from 
other cellular sources may contribute to NKT cell production of 
IFN-γ in response to α-GalCer challenge. This view is supported 
by reduced percentages of IFN-γ+ liver CD3+NK1.1+ cells in mice 
treated with IWP-2 (37) (Figure 6B), a small molecule inhibitor 
of the acyltransferase Porcupine, which plays a central role in Wnt 
secretion (14). In contrast to the impact on IFN-γ, Wls deletion 
in myeloid cells did not affect α-GalCer-induced IL-4 responses 
in the first 6 h post challenge (data not shown).
While APCs are not only known sources but also targets of 
Wnt ligands, much less is known about the potential of NKT cells 
to respond to Wnt signals. We thus assessed whether NKT cells 
are, in principle, equipped to respond to Wnt ligands. To this end, 
we performed microarray analyses on α-GalCer-CD1d-tetramer+ 
TCRβ+ NK1.1+ cells sorted from mouse liver tissue. Indeed, 
NKT  cells express Wnt receptors and co-receptors, β-catenin, 
components of the β-catenin destruction complex and down-
stream transcription factors, and there were no apparent differ-
ences between the predominant CD4+ and CD4− liver NKT cell 
subsets (Figure  6C; Figure S4 in Supplementary Material). 
Collectively, these data suggest temporal and differential contri-
butions of Wnt proteins to α-GalCer-induced IFN-γ responses at 
different stages post challenge, and implicate myeloid cells as a 
cellular source of Wnt proteins in vivo that shapes the functional 
output of NKT cells.
DiscUssiOn
Studies on contributions of β-catenin activity and Wnt ligands to 
NKT cell functions in vivo have been hampered by the impact of 
genetic modulation of β-catenin expression on NKT cell develop-
ment, as well as the limited availability of animal models suitable 
to assess Wnt functions in the adult organism in vivo. Through 
pharmacologic and conditional genetic targeting of β-catenin 
activity and key factors that drive Wnt release, collectively the 
data presented in this study support the conclusions that in 
response to the NKT  cell antigen α-GalCer: (i) Wnt/β-catenin 
signaling in the liver environment regulates IFN-γ responses; 
(ii) active suppression of hepatic Wnt/β-catenin signaling shortly 
after α-GalCer exposure biases cytokine responses toward IFN-γ 
production; (iii) β-catenin activity independent of APC-derived 
Wnt ligands contributes to IL-4 expression by NKT cells; (iv) Wnt 
ligands that act via β-catenin-independent signaling contribute 
to the perpetuation of IFN-γ responses within several hours 
post challenge; and (v) myeloid-derived Wnt ligands are, in part, 
responsible for these regulatory effects on NKT cells.
Our findings on the reciprocal contributions of β-catenin to 
IL-4 and IFN-γ expression by NKT cells are in concordance with 
a previous report (20) and affirm a role of β-catenin in shaping 
the functional output from developmentally normal NKT cells. 
However, in contrast to the assumption that β-catenin-mediated 
effects on NKT  cell functions are the result of Wnt signaling, 
our data do not support a direct role of Wnt ligands in driv-
ing these β-catenin functions in the in vivo model of α-GalCer 
challenge. It is important to note that β-catenin activation is 
not exclusively driven by Wnt ligands and can, for example, be 
induced by microbial ligands and hepatic growth factor (38–40). 
Thus, combined manipulation of both Wnt ligand availability 
and β-catenin activity offer opportunities for refined insights 
into the contributions of Wnt/β-catenin signaling in complex 
FigUre 5 | Wnt/β-catenin signaling is suppressed in the liver upon α-galactosylceramide (α-GalCer) challenge. (a) Heat map of fold change of Wnt ligand mRNA 
expression in the liver compared to vehicle control-injected mice determined by quantitative RT-PCR (blue = downregulation, red = upregulation). Numbers within the 
table represent relative gene expression for individual genes normalized to Hprt, expressed as mean (×10−5) ± SEM (×10−5). The mRNA expression of Dkk1 (b) and 
Sfrp1 (c) was determined. (D) Tcf/Lef TOPFlash mice, expressing luciferase as a reporter of Tcf/Lef transcriptional activity, and transgene-negative littermate controls 
were challenged with α-GalCer or vehicle control for 6 h. Luciferase expression in liver tissue was determined by quantitative PCR. Expression of Ifng was determined 
as a marker of activation after α-GalCer challenge. Data are means ± SEM of four to nine mice per time point from three (a–c) or two (D) independent experiments. 
One-way ANOVA with Dunnett’s (a–c) and two-way ANOVA with Bonferroni’s (D) correction for multiple comparisons; *p < 0.05, **p < 0.01, ****p < 0.0001.
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in  vivo settings. Whereas we find it encouraging that ICG001 
administration to adult mice showed similar effects on NKT cell 
IL-4 and IFN-γ expression as genetic ablation (20), obvious 
limitations of the approach taken here is that ICG001 is likely 
to impair β-catenin functions in a broad range of cells and only 
targets β-catenin/CBP interactions. Future studies may focus on 
cell-specific deletion approaches, preferably inducible in adult 
tissues, to further underpin the roles of β-catenin in NKT cell 
functions.
The notion that β-catenin-independent Wnt signaling 
promotes, whereas Wnt/β-catenin signaling suppresses IFN-γ 
responses is consistent with the current paradigm of pro- versus 
anti-inflammatory functions of specific Wnt signaling modali-
ties. For example, in a model of DSS-induced colitis, tamoxifen-
induced conditional knockout of Wnt5a resulted in reduced 
expression of IL-12 and IFN-γ in the colon (41). Neutralizing 
antibodies against Wnt5a or its receptor Fzd5 impaired antigen-
specific IL-12 and IFN-γ responses in PBMC cultures (22). By 
contrast, Wnt/β-catenin signaling has been attributed immune-
modulatory functions via the induction of anti-inflammatory, 
and repression of pro-inflammatory cytokine expression in 
APCs (36, 40, 42). For example, β-catenin deletion in CD11c+ 
FigUre 6 | Wnt proteins secreted by myeloid cells upon α-galactosylceramide (α-GalCer) challenge regulate the interferon gamma (IFN-γ) response. (a) Mice  
with a conditional knockout of Wls (Wlsfl/fl LysM-Cre+) and littermate controls (Wlsfl/fl LysM-Cre−) were challenged with α-GalCer. Percentages of CD3+NK1.1+ natural 
killer T (NKT) cells expressing IFN-γ in the liver, and the serum levels of IFN-γ were analyzed. Data are means ± SEM of four to six mice per genotype (n = 2 for  
4.5 h Wlsfl/fl LysM-Cre− group) per time point cumulatively analyzed in four independent experiments. (b) Percentages of CD3+NK1.1+ NKT cells expressing IFN-γ 
was determined by flow cytometry in mice treated with DMSO or the Porcupine inhibitor, IWP2. Data are means ± SEM of four to nine mice per treatment for each 
time point from two to three independent experiments. At each time point, groups in panels (a,b) were compared using unpaired two-sided t-test; *p < 0.05.  
(c) Mircoarray-based gene expression analyses of sorted CD4− (and CD8-negative, DN) and CD4+ liver NKT cells were analyzed for the expression of Wnt  
signaling components. Data are presented as mean ± SEM. The threshold was set at the expression level of Il12a, which is not expressed by NKT cells.
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cells impaired pro-inflammatory cytokine responses, including 
IL-12, in intestinal APCs and enhanced pathology in a colitis 
model. This was attributed to a shift toward pathogenic Th1 and 
Th17 cells at the expense of regulatory T cells in the intestine 
(43). However, it is important to note that β-catenin activity in 
regulatory T cells impairs their functions and drives colitis and 
tumor development (44, 45). Moreover, we recently demon-
strated that pharmacologic targeting of both β-catenin activity 
and Wnt production impaired pro-inflammatory cytokine 
responses in an endotoxemia model in mice (46), indicating 
pro-inflammatory functions of Wnt/β-catenin signaling in this 
context. Future studies will focus on identifying individual Wnt/
Wnt receptor combinations that shape NKT cell functions and 
fate, as well as the specific cellular sources of the Wnt ligands that 
regulate cytokine production by NKT cells. In addition, defin-
ing whether Wnt proteins exert their functions through direct 
signaling in NKT  cells or other cells such as APCs, will help 
delineate the complex temporal contributions of Wnt ligands to 
NKT cell-mediated immune responses.
Our findings and previous reports emphasize the plethora of 
Wnt ligands and components of the Wnt signaling machinery 
that are expressed in liver tissue and are dynamically regulated 
in response to pathological challenges (7, 35, 47). Repeated 
exposure to the NKT cell antigen α-GalCer results in enhanced 
β-catenin signaling in mouse liver tissue, which has been asso-
ciated with NKT cell anergy in response to chronic activation, 
and suppresses both IFN-γ and IL-4 production (48). Together 
with the findings presented here and by others (20), this suggests 
that transient suppression of Wnt/β-catenin activity after initial 
challenge, combined with β-catenin-independent Wnt signal-
ing, biases NKT cell functions toward IFN-γ production, while 
limiting the IL-4 response. Suppression of IFN-γ responses by 
Wnt/β-catenin signaling would thus be consistent at all stages 
of NKT  cell activation. In this context, it is interesting to note 
that early during α-GalCer challenge, the majority of the IL-4+ 
CD3+ NK1.1+ cells also expressed IFN-γ (79.03 ± 1.5% at 1.5 h). 
Whereas this dual-functionality of IL-4+ NKT  cells gradually 
declined (54.3 ± 10.9% at 6 h) neither Porcupine nor β-catenin 
inhibition affected the percentage of IFN-γ+ cells in the IL-4+ 
CD3+ NK1.1+ population (data not shown). Thus, functionally 
distinct NKT cell subsets may be selectively responsive to Wnt-
mediated regulation of IFN-γ.
The specific molecular mechanisms by which β-catenin 
may enhance NKT  cell-mediated IL-4 responses early dur-
ing NKT cell activation but limit this response upon chronic 
exposure remain to be determined. In this context, it is 
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FigUre 7 | Proposed model of the temporal contributions of Wnt ligands and β-catenin to α-galactosylceramide (α-GalCer)-induced interferon gamma (IFN-γ)  
and IL-4 responses by liver natural killer T (NKT) cells. (a) Wnt production by myeloid cells and Wnt/β-catenin signaling negatively regulate early IFN-γ expression  
by NKT cells during α-GalCer challenge. Within hours after α-GalCer exposure, Wnt ligand expression in the liver environment is largely suppressed. This is 
accompanied by increased expression of endogenous Wnt signaling inhibitors such as Dkk1 and Sfrp1, as well as suppression of Tcf/Lef-driven transcriptional 
activity. Suppression of Wnt/β-catenin signaling favors IFN-γ expression by NKT cells, which is partially supported by β-catenin-independent signaling events  
driven by Wnt ligands originating largely from non-myeloid cells. (b) β-catenin activity contributes to IL-4 expression by liver NKT cells independent of Wnt ligand 
production, at least during the first 6 h analyzed in the mouse model utilized here. While NKT cells are, in principle, equipped with the signaling machinery required  
to relay Wnt signaling via β-catenin-dependent and -independent pathways as depicted in this model, direct experimental evidence for contributions of these 
molecular networks in NKT cells is pending. Moreover, it is important to emphasize that the effects of Wnt pathway perturbation on NKT cell cytokine  
responses may also result from indirect effects of Wnt ligands on other cells, such as antigen-presenting cells (APCs), NK cells, and hepatocytes.
interesting to note that the Wnt ligands whose expression was 
increased in liver tissue during chronic α-GalCer exposure 
(Wnt3a, Wnt5a, Wnt7a, Wnt7b, and Wnt10a) (48), displayed 
in our study mRNA expression levels below the detection limit 
(Wnt3a Wnt7a, Wnt7b, Wnt10a), or no significant changes in 
their expression (Wnt5a) during the first 6 h following a single 
α-GalCer injection. This indicates that different subsets of Wnt 
ligands in the liver microenvironment, in concert with other 
cytokines and growth factors, may shape NKT cell functions at 
different stages of activation when compared to anergy. While 
the specific functional contributions of individual Wnt ligands 
remain to be established, it is tempting to speculate that this 
may be reflective of the interaction of NKT cells with different 
cellular sources of Wnt proteins. There is indeed precedence 
for differential roles of Wnt proteins in the liver environment 
depending on the cellular source. Whereas macrophage-
derived Wnt proteins promote liver regeneration after partial 
hepatectomy, Wnt proteins expressed by epithelial cells did not 
contribute to this process (6).
Taken together, the data presented in this study implicate 
Wnt proteins as regulators of NKT cell functionality in the liver 
environment (Figure 7). Several small molecule inhibitors that 
target Wnt production and β-catenin activity are currently in 
clinical trials (49). NKT  cells not only have pathogenic roles, 
such as in non-alcoholic fatty liver disease and toxin-induced 
hepatitis (50), but also exert protective functions, for example, 
due to IFN-γ-mediated repression of hepatitis B virus replication 
in hepatocytes (51). Thus, detailed understanding of the roles 
of Wnt proteins and β-catenin in defining NKT  cell functions 
in health and disease may not only be exploited therapeutically 
by targeted skewing of NKT cell functions but may also reveal 
potential for adverse outcomes of pharmacologic Wnt pathway 
perturbation.
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FigUre s1 | NK cell- and T cell-derived interferon gamma (IFN-γ). The percentage 
of CD3+NK1.1− T cells (a) and CD3-NK1.1+ NK cells (b) in the liver expressing 
IFN-γ in response to α-galactosylceramide (α-GalCer) challenge was determined 
by flow cytometry. Expression of IL-4 by CD3+NK1.1− T cells (c) and CD3−NK1.1+ 
NK cells (D) in the liver was determined. Data are means ± SEM of four to  
seven mice per time point analyzed cumulatively in two independent experiments. 
Groups were compared by one-way ANOVA with Dunnett’s correction for  
multiple comparisons; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
FigUre s2 | Characterization of myeloid cell populations in the liver. Mice  
were treated with DMSO or ICG001 prior to challenge with α-galactosylceramide 
(α-GalCer) for 1.5 h. (a) The percentage of Ly6Chi and Ly6Clo monocytes 
(CD11b+Ly6G−) in the liver was determined. (b) The liver mRNA expression of 
Cd40, a costimulatory molecule expressed on antigen-presenting cells was 
determined by quantitative PCR (**p < 0.01). Data are means ± SEM of four to 
nine mice per treatment for each time point analyzed in two to three independent 
experiments. Groups were compared by (a) two-way ANOVA with Bonferroni’s 
correction for multiple comparisons; (b) unpaired two-sided t test; **p < 0.01.
FigUre s3 | Characterization of conditional Wls knockout mice. (a) The 
percentages of CD3+NK1.1+ natural killer T cells in the liver were determined by 
flow cytometry. (b) The mRNA expression of Cd1d was determined in liver tissue 
after α-galactosylceramide challenge in mice with a conditional knockout of Wls 
(Wlsfl/fl LysM-Cre+) and their littermate controls (Wlsfl/fl LysM-Cre−). (c) Bone 
marrow-derived macrophages were cultured for 6 days in the presence of L 
cell-conditioned medium. mRNA expression of Cd1d was determined by qPCR. 
Data are means ± SEM of cultures from 7 Cre− and 10 Cre+ individual mice.  
(D) The percentages of CD3−NK1.1+ NK cells in the liver expressing interferon 
gamma (IFN-γ) were determined by flow cytometry. Data in panels (a,b,D) are 
from n = 4–6 mice per genotype for each time point (n = 2 for 4.5 h Wlsfl/fl 
LysM−Cre− group) from four independent experiments. Groups were compared 
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